Skip to main content

Affinity for Both 5-HT1A- and D1-Receptors and Anxiolytic Activity of N-(Arylpiperazinylalkyl) Phthalimides

  • Conference paper
Molecular Recognition and Inclusion

Abstract

The aryl(hetaryl)piperazine derivatives form numerous group of anxiolytics of novel generation. They influence on the neuromediator processes of CNS through the binding with the serotonin and dopamine brain receptors. The analysis of buspiron (I) and of some its analogs influence on neuronal and behavioural reactions of animals allow to conclude that at least two components: serotoninomimetic and dopaminolytic are responsible for the demonstration of anxiolytic activity [1,2]. More over, analogs of buspiron: hepiron (II) and ipsapiron (III), which do not interact with dopaminergic brain systems, demonstrate more low anxiolytic activity in comparison with buspiron [2,3].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. New, J.S. (1990) The discovery and the development of Buspirone: A new approach to the treatment of Anxiety, Medicinal Research Reviews 10, 286–326.

    Article  Google Scholar 

  2. Abramets, I.I., Obraztsova, O.G., Samoylovich, J.M. and Kharin N.A. (1992) Serotonin-and dopaminergic mechanisms in action of the 1-pyrimidinylpiperazine derivatives, Eksperimentalnaya i klinicheskaya farmakologiya 55, 8–11.

    CAS  Google Scholar 

  3. Dompert, W.U., Glaser, T. and Trafer, J. (1985) 3H-TVX Q 7821: identification of 5-HT1 binding sites as target for a novel putative anxiolytic, Naunym-Shmidebergs Arch Pharmacol. 328, 467–470.

    Article  CAS  Google Scholar 

  4. Kathy, M., O’Beyle and Waddington, J.L. (1992) Agonist and antagonist interaction with D1 dopamine receptors agonist — induced masking of D1 receptors depends on intrinsic activity, Neuropharmacology 2, 177–183.

    Google Scholar 

  5. Andronati, S.A., Varava, V.M., Soboleva, S.G., et al. (1992) 1-Phenyl-4-[4-(N-naph-thalimido)butyl]piperazin novel ligand of serotonin receptors, Dokl. Akad. Nauk. 327, 341–344.

    CAS  Google Scholar 

  6. Voronina, T.A., Vikhliaev, Yu.I., Nerobkova L.N., et al.(1982) Characteristic of the pharmacologic properties of phenazepam, in A.V. Bogatsky (eds) Phenazepam, Naukova Dumka Publishers, Kyiv, p.p. 146–147.

    Google Scholar 

  7. Free, S.M. and Wilson, J.M. (1964) A Mathematical contribution to structure-activity studies, J. Med Chem. 7, 395–399.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media Dordrecht

About this paper

Cite this paper

Andronati, S.A., Voronina, T.A., Sava, V.M., Molodavkin, G.M., Makan, S.Y., Soboleva, S.G. (1998). Affinity for Both 5-HT1A- and D1-Receptors and Anxiolytic Activity of N-(Arylpiperazinylalkyl) Phthalimides. In: Coleman, A.W. (eds) Molecular Recognition and Inclusion. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-5288-4_32

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-5288-4_32

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-6226-8

  • Online ISBN: 978-94-011-5288-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics